It is possible that the main title of the report Chronic Lymphocytic Leukemia is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Radiation may be the preferred modality where the functional deficit will be great, such as the tongue base or tonsil, as shown in the RTOG-9003 trial, for example.
Surgery may be the preferred modality where the functional deficit will be minimal, such as tonsil pillar.
When radiation is given, careful choice of radiation technique by a radiation oncologist experienced in managing head and neck cancers is essential. The choice of treatment is dictated by the anticipated functional, cosmetic, and socioeconomic results of the treatment options as well as by the available expertise of the surgeon or radiation therapist. Treatment is individualized for each patient.
Treatment options under clinical evaluation:
Radiation clinical trials evaluating hyperfractionation schedules should be considered.
Current Clinical Trials
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I oropharyngeal cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.